The global clinical trials imaging market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing number of clinical trials and rising demand for imaging devices in hospitals and clinics.
The global clinical trials imaging market is segmented on the basis of type, application, and region. On the basis of type, it is classified into computed tomography (CT), ultrasound (US), echocardiography (ECG), magnetic resonance imaging (MRI), positron emission tomography (PET) and ray modalities. On the basis of application, it includes biotechnology companies, pharmaceutical companies, contract research organizations (CROs), medical device manufacturers, academic and government research institutes. On the basis of region it includes North America, Latin America Europe Asia Pacific Middle East & Africa.
-The global clinical trials imaging market is expected to grow at a CAGR of 7.2% from 2017 to 2022.
-Increasing number of clinical trials and rising awareness about the benefits of imaging in the diagnosis and treatment of various diseases are driving the growth of this market.
-Increasing adoption rate for advanced technologies such as MRI, CT scan, PET scan, and ultrasound are also driving the growth of this market.
-In addition, increasing government funding for research & development activities in developing countries such as China and India is also driving the growth of this market.
-However, high cost associated with these technologies may hamper the growth prospects for this market over time.
Industry Growth Insights published a new data on “Clinical Trials Imaging Market”. The research report is titled “Clinical Trials Imaging Market research by Types (Computed Tomography, Ultrasound, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, X-Ray, Other Modalities), By Applications (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Medical Device Manufacturers, Academic and Government Research Institutes, Others), By Players/Companies Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies, Intrinsic Imaging, Worldcare Clinical, Virtualscopics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Trials Imaging Market Research Report
By Type
Computed Tomography, Ultrasound, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, X-Ray, Other Modalities
By Application
Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Medical Device Manufacturers, Academic and Government Research Institutes, Others
By Companies
Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies, Intrinsic Imaging, Worldcare Clinical, Virtualscopics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Trials Imaging Market Report Segments:
The global Clinical Trials Imaging market is segmented on the basis of:
Types
Computed Tomography, Ultrasound, Echocardiography, Magnetic Resonance Imaging, Positron Emission Tomography, X-Ray, Other Modalities
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Medical Device Manufacturers, Academic and Government Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bioclinica
- Parexel International
- Radiant Sage
- Biomedical Systems
- Biotelemetry
- Icon
- IXICO
- Cardiovascular Imaging Technologies
- Intrinsic Imaging
- Worldcare Clinical
- Virtualscopics
Highlights of The Clinical Trials Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Computed Tomography
- Ultrasound
- Echocardiography
- Magnetic Resonance Imaging
- Positron Emission Tomography
- X-Ray
- Other Modalities
- By Application:
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organizations
- Medical Device Manufacturers
- Academic and Government Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trials Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical Trials Imaging is a type of medical imaging that can be used to help doctors and researchers study the effects of treatments on patients. Clinical Trials Imaging can help doctors see how well treatments are working by providing pictures and data about how patients are responding.
Some of the major companies in the clinical trials imaging market are Bioclinica, Parexel International, Radiant Sage, Biomedical Systems, Biotelemetry, Icon, IXICO, Cardiovascular Imaging Technologies, Intrinsic Imaging, Worldcare Clinical, Virtualscopics.
The clinical trials imaging market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Trials Imaging Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clinical Trials Imaging Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clinical Trials Imaging Market - Supply Chain
4.5. Global Clinical Trials Imaging Market Forecast
4.5.1. Clinical Trials Imaging Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clinical Trials Imaging Market Size (000 Units) and Y-o-Y Growth
4.5.3. Clinical Trials Imaging Market Absolute $ Opportunity
5. Global Clinical Trials Imaging Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Clinical Trials Imaging Market Size and Volume Forecast by Type
5.3.1. Computed Tomography
5.3.2. Ultrasound
5.3.3. Echocardiography
5.3.4. Magnetic Resonance Imaging
5.3.5. Positron Emission Tomography
5.3.6. X-Ray
5.3.7. Other Modalities
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Clinical Trials Imaging Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Clinical Trials Imaging Market Size and Volume Forecast by Application
6.3.1. Biotechnology Companies
6.3.2. Pharmaceutical Companies
6.3.3. Contract Research Organizations
6.3.4. Medical Device Manufacturers
6.3.5. Academic and Government Research Institutes
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Clinical Trials Imaging Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Clinical Trials Imaging Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Clinical Trials Imaging Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Clinical Trials Imaging Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Clinical Trials Imaging Demand Share Forecast, 2019-2029
9. North America Clinical Trials Imaging Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Clinical Trials Imaging Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Clinical Trials Imaging Market Size and Volume Forecast by Application
9.4.1. Biotechnology Companies
9.4.2. Pharmaceutical Companies
9.4.3. Contract Research Organizations
9.4.4. Medical Device Manufacturers
9.4.5. Academic and Government Research Institutes
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Clinical Trials Imaging Market Size and Volume Forecast by Type
9.7.1. Computed Tomography
9.7.2. Ultrasound
9.7.3. Echocardiography
9.7.4. Magnetic Resonance Imaging
9.7.5. Positron Emission Tomography
9.7.6. X-Ray
9.7.7. Other Modalities
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Clinical Trials Imaging Demand Share Forecast, 2019-2029
10. Latin America Clinical Trials Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Clinical Trials Imaging Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Clinical Trials Imaging Market Size and Volume Forecast by Application
10.4.1. Biotechnology Companies
10.4.2. Pharmaceutical Companies
10.4.3. Contract Research Organizations
10.4.4. Medical Device Manufacturers
10.4.5. Academic and Government Research Institutes
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Clinical Trials Imaging Market Size and Volume Forecast by Type
10.7.1. Computed Tomography
10.7.2. Ultrasound
10.7.3. Echocardiography
10.7.4. Magnetic Resonance Imaging
10.7.5. Positron Emission Tomography
10.7.6. X-Ray
10.7.7. Other Modalities
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Clinical Trials Imaging Demand Share Forecast, 2019-2029
11. Europe Clinical Trials Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Clinical Trials Imaging Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Clinical Trials Imaging Market Size and Volume Forecast by Application
11.4.1. Biotechnology Companies
11.4.2. Pharmaceutical Companies
11.4.3. Contract Research Organizations
11.4.4. Medical Device Manufacturers
11.4.5. Academic and Government Research Institutes
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Clinical Trials Imaging Market Size and Volume Forecast by Type
11.7.1. Computed Tomography
11.7.2. Ultrasound
11.7.3. Echocardiography
11.7.4. Magnetic Resonance Imaging
11.7.5. Positron Emission Tomography
11.7.6. X-Ray
11.7.7. Other Modalities
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Clinical Trials Imaging Demand Share, 2019-2029
12. Asia Pacific Clinical Trials Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Clinical Trials Imaging Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Clinical Trials Imaging Market Size and Volume Forecast by Application
12.4.1. Biotechnology Companies
12.4.2. Pharmaceutical Companies
12.4.3. Contract Research Organizations
12.4.4. Medical Device Manufacturers
12.4.5. Academic and Government Research Institutes
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Clinical Trials Imaging Market Size and Volume Forecast by Type
12.7.1. Computed Tomography
12.7.2. Ultrasound
12.7.3. Echocardiography
12.7.4. Magnetic Resonance Imaging
12.7.5. Positron Emission Tomography
12.7.6. X-Ray
12.7.7. Other Modalities
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Clinical Trials Imaging Demand Share, 2019-2029
13. Middle East & Africa Clinical Trials Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Clinical Trials Imaging Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Clinical Trials Imaging Market Size and Volume Forecast by Application
13.4.1. Biotechnology Companies
13.4.2. Pharmaceutical Companies
13.4.3. Contract Research Organizations
13.4.4. Medical Device Manufacturers
13.4.5. Academic and Government Research Institutes
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Clinical Trials Imaging Market Size and Volume Forecast by Type
13.7.1. Computed Tomography
13.7.2. Ultrasound
13.7.3. Echocardiography
13.7.4. Magnetic Resonance Imaging
13.7.5. Positron Emission Tomography
13.7.6. X-Ray
13.7.7. Other Modalities
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Clinical Trials Imaging Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Clinical Trials Imaging Market: Market Share Analysis
14.2. Clinical Trials Imaging Distributors and Customers
14.3. Clinical Trials Imaging Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bioclinica
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Parexel International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Radiant Sage
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biomedical Systems
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biotelemetry
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Icon
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. IXICO
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cardiovascular Imaging Technologies
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Intrinsic Imaging
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Worldcare Clinical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Virtualscopics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
&n
